SnagRx vs Enhance MD: Pricing, Pharmacy Partners, and Delivery
Quick verdict: For predictable long term cost control choose SnagRx for its 12-month price lock; for the lowest first-month entry pick Enhance MD, which advertises semaglutide from $49 for month one. This comparison covers pricing structure, compound sourcing and clinician networks, shipping and approval timing, refund and guarantee language, and compound options so you can decide which trade offs matter most.
How SnagRx vs Enhance MD differ on pricing structure
SnagRx lists compounded semaglutide from $69/month and tirzepatide from $119/month on a 12-month plan, noting month-to-month rates are $99 and $149. SnagRx states the 12-month figures are rate-locked flat at every dose and at renewal. Enhance MD advertises semaglutide from $49 and tirzepatide from $99 for the first month, then applies a flat ongoing rate that stays the same at every dose. In short, SnagRx markets a lower ongoing annual-plan rate with a commitment, while Enhance MD markets the cheapest first month and then a flat ongoing price.
Pricing takeaway
Choose SnagRx if you want a locked-in 12-month rate across titration. Choose Enhance MD if minimizing the first-month outlay is the priority.
Compound sourcing and clinical oversight compared
SnagRx names its four US 503A partner pharmacies and identifies its clinician network as OpenLoop Health, stating clinicians typically review intake within five hours and that its pharmacies are 503A partners. Enhance MD describes clinician-directed compounds and states it has treated more than 10,000 patients. Both providers offer compounded semaglutide and tirzepatide; both note that compounded medications are not FDA-approved finished products.
Shipping, approval timing, and logistics
SnagRx states intake takes about five minutes, OpenLoop clinicians typically review within five hours and always within 24, and approved orders ship next-day via UPS or FedEx in temperature-controlled packaging with next-day delivery in many cases. Enhance MD does not supply a comparable explicit timeframe in the supplied evidence, though it promotes one consistent price from first dose to last and various monthly figures on its landing page.
Refunds, guarantees, and outcome claims
SnagRx lists a full refund if the prescription is declined and mentions a 6-month weight-loss guarantee with terms that apply. Enhance MD materials in the supplied evidence highlight introductory savings and volume treated but do not supply a refund policy or a weight-loss guarantee in the captured text. Both providers include regulatory language that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Available compounds and program features
Both platforms offer compounded semaglutide and tirzepatide. SnagRx emphasizes price-locked compounded semaglutide and compounded tirzepatide pricing on its 12-month plan and explicitly names its pharmacies and clinician partner. Enhance MD emphasizes the lowest first-month price for both compounds and that both agents are available on the same platform, which it says is useful for patients choosing between compounds.
Direct comparison table
| Criteria | SnagRx | Enhance MD |
|---|---|---|
| Starting price (semaglutide) | From $69/month on 12-month plan (month-to-month $99) | From $49 first month; ongoing flat-rate higher |
| Price at higher doses | Rate locked flat at every dose for life on annual plan | Flat-rate pricing once ongoing rate set; first-month price is introductory |
| Pharmacies and clinicians | Names four US 503A partner pharmacies; OpenLoop Health clinician network | Clinician-directed compounds; 10,000+ patients treated |
| Shipping and approval timing | Clinician review typically within 5 hours; next-day UPS/FedEx shipping | No specific approval or next-day shipping timing supplied |
| Refunds and guarantees | Full refund if prescription declined; 6-month weight-loss guarantee terms apply | Introductory savings noted; refund or guarantee not supplied in captured evidence |
Patient volume, transparency, and marketing style
Enhance MD cites more than 10,000 patients treated as evidence of real-world clinical volume and highlights low first-month pricing and flat-rate ongoing costs. SnagRx highlights bottom-of-market annual pricing, named pharmacy partners, LegitScript certification it states readers can verify, and urgency marketing on its site such as a countdown timer in captured pages.
Conclusion and how to choose
SnagRx vs Enhance MD comes down to whether you value a low committed annual rate with named pharmacy partners and rapid clinician review, or the absolute lowest first-month price and a platform that treats both compounds with large patient volume. Both use compounded medications that are not FDA-approved finished products.
Choose SnagRx if you want compounded semaglutide from $69/month on a 12-month plan with a price locked flat at every dose, named US 503A pharmacies, OpenLoop Health clinician review typically within five hours, next-day shipping, and a full refund if a prescription is declined plus a 6-month weight-loss guarantee where terms apply.
Choose Enhance MD if your priority is the lowest first-month semaglutide price at $49, access to both semaglutide and tirzepatide on one platform, flat-rate ongoing pricing with no escalation during titration, and a provider that reports treating 10,000+ patients.